Search research articles
Contact Us
Filters
Showing results (51-60 of 74) with videos related to
Page
of 8
Sort By:
Journal of Medicinal Chemistry
|
December 3, 2015
[(18)F]Fluorobenzoyllysinepentanedioic Acid Carbamates: New Scaffolds for Positron Emission Tomography (PET) Imaging of Prostate-Specific Membrane Antigen (PSMA)
Xing Yang, Ronnie C Mease, Mrudula Pullambhatla, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 17, 2008
N-[N-[(S)-1,3-Dicarboxypropyl]carbamoyl]-4-[18F]fluorobenzyl-L-cysteine, [18F]DCFBC: a new imaging probe for prostate cancer
Ronnie C Mease, Crystal L Dusich, Catherine A Foss, et al.
Journal of Labelled Compounds & Radiopharmaceuticals
|
February 12, 2021
Process validation, current good manufacturing practice production, dosimetry, and toxicity studies of the carbonic anhydrase IX imaging agent [<sup>111</sup> In]In-XYIMSR-01 for phase I regulatory approval
Ravindra A De Silva, Michael A Gorin, Ronnie C Mease, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 28, 2015
Preclinical evaluation of 86Y-labeled inhibitors of prostate-specific membrane antigen for dosimetry estimates
Sangeeta Ray Banerjee, Catherine A Foss, Mrudula Pullambhatla, et al.
Molecules (Basel, Switzerland)
|
April 5, 2020
In Vitro and In Vivo Characterization of Dibenzothiophene Derivatives [<sup>125</sup>I]Iodo-ASEM and [<sup>18</sup>F]ASEM as Radiotracers of Homo- and Heteromeric α7 Nicotinic Acetylcholine Receptors
Cornelius K Donat, Henrik H Hansen, Hanne D Hansen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 30, 2019
Preclinical Evaluation of <sup>203/212</sup>Pb-Labeled Low-Molecular-Weight Compounds for Targeted Radiopharmaceutical Therapy of Prostate Cancer
Sangeeta Ray Banerjee, Il Minn, Vivek Kumar, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 5, 2021
An Improved <sup>211</sup>At-Labeled Agent for PSMA-Targeted α-Therapy
Ronnie C Mease, Choong Mo Kang, Vivek Kumar, et al.
Oncotarget
|
September 30, 2015
Imaging of carbonic anhydrase IX with an 111In-labeled dual-motif inhibitor
Xing Yang, Il Minn, Steven P Rowe, et al.
Science Advances
|
July 20, 2022
Polymeric nanoparticles for dual-targeted theranostic gene delivery to hepatocellular carcinoma
Hannah J Vaughan, Camila G Zamboni, Laboni F Hassan, et al.
Molecular Imaging and Biology
|
April 16, 2016
PSMA-Based [(18)F]DCFPyL PET/CT Is Superior to Conventional Imaging for Lesion Detection in Patients with Metastatic Prostate Cancer
Steven P Rowe, Katarzyna J Macura, Esther Mena, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 74) with videos related to
Sort By:
Page
of 8
Journal of Medicinal Chemistry
|
December 3, 2015
[(18)F]Fluorobenzoyllysinepentanedioic Acid Carbamates: New Scaffolds for Positron Emission Tomography (PET) Imaging of Prostate-Specific Membrane Antigen (PSMA)
Xing Yang, Ronnie C Mease, Mrudula Pullambhatla, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 17, 2008
N-[N-[(S)-1,3-Dicarboxypropyl]carbamoyl]-4-[18F]fluorobenzyl-L-cysteine, [18F]DCFBC: a new imaging probe for prostate cancer
Ronnie C Mease, Crystal L Dusich, Catherine A Foss, et al.
Journal of Labelled Compounds & Radiopharmaceuticals
|
February 12, 2021
Process validation, current good manufacturing practice production, dosimetry, and toxicity studies of the carbonic anhydrase IX imaging agent [<sup>111</sup> In]In-XYIMSR-01 for phase I regulatory approval
Ravindra A De Silva, Michael A Gorin, Ronnie C Mease, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 28, 2015
Preclinical evaluation of 86Y-labeled inhibitors of prostate-specific membrane antigen for dosimetry estimates
Sangeeta Ray Banerjee, Catherine A Foss, Mrudula Pullambhatla, et al.
Molecules (Basel, Switzerland)
|
April 5, 2020
In Vitro and In Vivo Characterization of Dibenzothiophene Derivatives [<sup>125</sup>I]Iodo-ASEM and [<sup>18</sup>F]ASEM as Radiotracers of Homo- and Heteromeric α7 Nicotinic Acetylcholine Receptors
Cornelius K Donat, Henrik H Hansen, Hanne D Hansen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 30, 2019
Preclinical Evaluation of <sup>203/212</sup>Pb-Labeled Low-Molecular-Weight Compounds for Targeted Radiopharmaceutical Therapy of Prostate Cancer
Sangeeta Ray Banerjee, Il Minn, Vivek Kumar, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 5, 2021
An Improved <sup>211</sup>At-Labeled Agent for PSMA-Targeted α-Therapy
Ronnie C Mease, Choong Mo Kang, Vivek Kumar, et al.
Oncotarget
|
September 30, 2015
Imaging of carbonic anhydrase IX with an 111In-labeled dual-motif inhibitor
Xing Yang, Il Minn, Steven P Rowe, et al.
Science Advances
|
July 20, 2022
Polymeric nanoparticles for dual-targeted theranostic gene delivery to hepatocellular carcinoma
Hannah J Vaughan, Camila G Zamboni, Laboni F Hassan, et al.
Molecular Imaging and Biology
|
April 16, 2016
PSMA-Based [(18)F]DCFPyL PET/CT Is Superior to Conventional Imaging for Lesion Detection in Patients with Metastatic Prostate Cancer
Steven P Rowe, Katarzyna J Macura, Esther Mena, et al.
Page
of 8